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Summary Mycobacterium neoaurum, a member of the Mycobacterium parafortuitum com-
plex, has only rarely been reported as a pathogen of human infections. We report a case of
catheter-related bloodstream infection (CRBSI) due toM. neoaurum in a patient on hemodialysis.
The isolate was identified by conventional methods as well as by 16S rRNA gene analysis. The
patient was successfully treated with intravenous antibiotics (meropenem and amikacin) for
three weeks and the catheter was removed. M. neoaurum should be considered as a possible
cause of CRBSI in patients with renal failure. Combination antimicrobial therapy and catheter
removal can lead to a favorable clinical outcome.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Mycobacterium neoaurum, a member of the Mycobacterium
parafortuitum complex, was first isolated from soil in 1972.1
M. neoaurum is considered an environmental organism and
has only rarely been reported as a pathogen of human
infections. Infection due to M. neoaurum includes blood-
stream infection,2 pulmonary infection,3 meningoencepha-
litis4 and urinary tract infection.5 Most of these infections
occur in patients with underlying malignancy or with indwel-
ling venous catheters, and in transplant recipients.2 Cathe-
ter-related infections due to M. neoaurum are extremely
rare in patients with renal failure.6,7 Here, we report a case* Corresponding author. Tel.: +886 2 23123456x5355;
fax: +886 2 23224263.
E-mail address: hsporen@ntu.edu.tw (P.-R. Hsueh).
1201-9712/$36.00 # 2008 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2008.11.001of catheter-related blood stream infection (CRBSI) due to M.
neoaurum in a patient on hemodialysis.
Case report
A46-year-oldmale presentedwith intermittent fever formore
than one month. He had a history of chronic alcoholic pan-
creatitis, diabetes mellitus (DM), hepatitis B virus infection,
alcohol-related liver disease and chronic kidney disease. He
was admitted for total hip and knee replacement as a result of
osteoarthritis in July 2007. During hospitalization, sudden
onset of left hemiplegia, slurred speech due to right thalamus
hemorrhage and several episodes of nosocomial infection
occurred. He also had intra-abdominal infection with abscess
formation and severe ileus, requiring continuing total parent-
eral nutrition via a central venous catheter (CVC). These
complications eventually led to acute respiratory failure withPublished by Elsevier Ltd. All rights reserved.
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Mycobacterium neoaurum infection during renal failure e277ventilator dependency and acute renal failure under regular
hemodialysis.
In April 2007, the patient developed fever with stable vital
signs, including temperature of 39 8C, pulse rate of 110/min,
respiratory rate of 22/min and blood pressure of 115/63
mmHg. Catheter placements at that time included one
CVC over the right neck, one double-lumen catheter (DLC)
over the right femoral area and three pig-tail catheters for
drainage of intra-abdominal abscess. No local inflammation
signs were found around these catheters. The white blood
cell count was 1.77  109/l, with neutrophil predominance
(81%), and the C-reactive protein level was elevated
(15.45 mg/dl). Empiric antibiotic treatment with ciproflox-
acin and amikacin was given after two sets of blood cultures
(BACTEC 9240, Becton Dickinson Diagnostic Instrument Sys-
tems, Sparks, MD, USA), one set from the CVC and another
from a peripheral vein, were drawn. Six days later, culture of
blood drawn from the CVC (aerobic bottle) grew acid-fast
bacilli. The catheter was removed and antibiotics were
changed to meropenem (500 mg every day) and amikacin
(300 mg every two days) because of suspected rapidly grow-
ing nontuberculous mycobacterium. Fever and leukocytosis
gradually improved after three days. The isolate was identi-
fied as M. neoaurum by conventional methods as well as by
16S rRNA gene (1464 base pairs) analysis.8 Repeated blood
cultures were negative and the patient remained well after
completing 21 days of antimicrobial therapy.
Discussion
M. neoaurum is one of the rapidly growing mycobacteria
species that are responsible for a variety of clinical syn-
dromes in humans, including CRBSIs. Infections due to M.
neoaurum are rare; most M. neoaurum bloodstream infec-
tions occur in immunocompromised hosts, such as patients
with solid cancer or leukemia, or transplant recipients.2 A
review of M. neoaurum infections in patients with renal
failure found only two reported cases.6,7 The clinical char-
acteristics of both of these patients and those of the present
case are summarized in Table 1. All three patients presented
with fever and had catheters (one peritoneal, two intravas-
cular) in place. Only one of the two patients with CRBSI had
localized evidence of catheter site infection (tenderness). All
of the patients were treated with catheter removal, but
antimicrobial management of the M. neoaurum infection
varied. All patients responded well to the treatment. In spite
of the limited number of cases, these findings suggest thatM.
neoaurum can cause catheter-related infection, including
peritoneal, arteriovenous (AV) graft and central venous
catheters, in patients with renal failure, and that successful
treatment can be achieved by removal of the catheter and
antimicrobial therapy.
Susceptibility testing of rapidly growing mycobacteria is
not standardized, and the optimal type and duration of
therapy remain to be defined. In a review by Washer
et al., M. neoaurum was most commonly susceptible to
imipenem, ciprofloxacin and amikacin, and combination
antimicrobial therapy should include macrolides, fluoroqui-
nolones or aminoglycosides.2 They also reported that device
removal can lead to favorable outcomes for M. neoaurum
bacteremia.2 We also found that, despite the use of various
combinations of antimicrobial agents in the three reported
e278 C.-C. Lai et al.cases, all of them were cured. Although this might imply that
the pathogenicity of M. neoaurum is low, susceptibility test-
ing should be standardized in order to indicate the appro-
priate antimicrobial agent for treating M. neoaurum.
In conclusion, M. neoaurum should be considered one of
the possible microorganisms that can cause catheter-related
infection in patients with renal failure. Combination anti-
microbial therapy and catheter removal can lead to excellent
clinical results.
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